ANTX
AN2 Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.96 / 10
Netural
Fund-flow data reveal a mixed but slightly positive bias: small-cap inflows are strong (trend positive), while block, medium, large, and extra-large flows show negative trends, with an overall fund-flow score of 6.99/10. Analyst coverage is limited to one provider (JMP Securities) with a Buy rating, but historical win-rate is low (0.0%), adding uncertainty. Together, the analyst and fund-flow picture supports a cautious stance.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-05-05
InstitutionJMP Securities
Times predicted3
Historical Win Rate33.3%
What is the market sentiment for ANTX?
- ANTX holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.96/10 (Netural).
